Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ATEA PHARMACEUTICALS, INC.

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR)
Listen to this Section


$4.30
-0.1200 ( -2.71% ) 110.5K

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Market Data


Open $4.30
Previous Close $4.42
Volume 110.5K
Market Cap $353.72M
Day Range $4.29 - $4.48
52 Week Range $2.78 - $6.45
Shares Outstanding 80.03M
Change % -2.71%
Net Change ▼ -0.1200
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -165,544.00

Date Type Amount Purchased Purchaser
2024-06-21 Sale -29600.00 Murphy Polly A.
2024-06-21 Sale -17544.00 Polsky Bruce
2024-06-21 Sale -29600.00 Lucidi Bruno
2024-06-21 Sale -29600.00 Adams Jerome M.
2024-06-21 Sale -29600.00 BERGER FRANKLIN M
2024-06-21 Sale -29600.00 Duncan Barbara Gayle

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 24, 2025
3 Insider transactions 2 Jun 24, 2025
8-k 8K-related 12 Jun 20, 2025

Latest News


× Before browsing our site, please accept our cookies policy